Related Experiment Video

Updated: Jul 13, 2025

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

4.6K

Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?

Yan-Ying Li1,2, Liu-Yun Zhang1,2, Yun-Hui Xiang1,2

  • 1School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Frontiers in Oncology
|October 12, 2023
PubMed

Insights

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are key in multiple myeloma (MM) bone disease and invasion. Understanding their roles offers new diagnostic and therapeutic strategies for MM.

Area of Science:

  • Oncology
  • Biochemistry
  • Pathology

Background:

  • Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are crucial in extracellular matrix (ECM) remodeling.
  • Multiple myeloma (MM) pathogenesis involves tumor invasion and osteolytic bone lesions, significantly influenced by MMPs and TIMPs.
  • MMPs degrade ECM components, promoting cancer cell invasion and metastasis, while TIMPs regulate MMP activity.

Purpose of the Study:

  • To review the specific roles of MMP-1, MMP-2, MMP-7, MMP-9, MMP-13, MMP-14, MMP-15, and TIMPs in multiple myeloma.
  • To explore their involvement in myeloma cell invasion, angiogenesis, and osteolytic bone disease.
  • To provide novel perspectives for clinical diagnostics and therapeutics in MM.

Main Methods:

  • Literature review focusing on MMPs and TIMPs in multiple myeloma.
  • Analysis of the pathophysiological mechanisms of MM bone disease and tumor invasion.
  • Synthesis of current knowledge on the roles of specific MMPs and TIMPs.

Main Results:

  • MMPs contribute significantly to myeloma bone disease by degrading collagen and promoting osteolysis.
  • MMPs and TIMPs are implicated in myeloma cell invasion, angiogenesis, and metastasis.
  • Specific MMPs (MMP-1, -2, -7, -9, -13, -14, -15) and TIMPs are identified as key players.

Conclusions:

  • MMPs and TIMPs are critical mediators in multiple myeloma progression, including bone destruction and tumor spread.
  • Targeting MMPs and TIMPs presents potential therapeutic avenues for managing MM and its complications.
  • Further research into these proteinases may lead to improved diagnostic markers and treatment strategies for MM patients.
Keywords:
matrix metalloproteinasemultiple myelomaneoplasm metastasisosteolytic bone diseasetissue inhibitor of metalloproteinases

More Related Videos

Detection of Functional Matrix Metalloproteinases by Zymography09:30

Detection of Functional Matrix Metalloproteinases by Zymography

Published on: November 8, 2010

84.0K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
9.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...
7.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K